Scientific Evidence – The Foundation of Efficacy and Safety
Atopic Dermatitis In Children
Our study confirmed that regular treatment with this specific probiotic mixture significantly decreased pruritus and sleep problems and improved quality of life in highly atopic children with severe atopic dermatitis.
Fragile X Syndrome (FXS)
This pilot study provides initial evidence that probiotics may modulate structural and functional properties of the GM, with potential links to improved behavioural outcomes in children with FXS.
Rheumatoid Arthritis
This randomized controlled trial demonstrates that adjunctive probiotic supplementation alongside conventional DMARD therapy significantly improves clinical outcomes in newly diagnosed rheumatoid arthritis patients over a period of 12 months.